Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterNo recent work listed

Wolfgang Weber

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7854-4345; OpenAlex author ID A5080877411; NIH RePORTER profile ID 8424847. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
1
Labs led
0
Collaborators
15
Papers, trials and grants by year

2019: 1 paper, 1 grant · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancer. Co-author DOI 10.1016/j.xcrm.2022.100815↗
  2. Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer. Last author DOI 10.1158/1078-0432.ccr-18-3667↗

Grants 1

  1. Histopathologic validation of 89Zr-DFO-HuMab-5B1 PET/CT imaging in CA 19-9 positive pancreatic cancer R01CA222049↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Neeta D. Pandit-Taskar · 1 shared paper, 1 shared grant, 2019 · strength 0.36
  2. Jason Stuart Lewis · 1 shared paper, 1 shared grant, 2019 · strength 0.36
  3. Michael Ian D'Angelica · 1 shared grant, 2019 · strength 0.28
  4. Katrin J. Frank · 1 shared paper, 2022 · strength 0.11
  5. Marina Lesina · 1 shared paper, 2022 · strength 0.11
  6. Kıvanç Görgülü · 1 shared paper, 2022 · strength 0.11
  7. Derya Kabacaoğlu · 1 shared paper, 2022 · strength 0.11
  8. Antonio Mulero‐Sánchez · 1 shared paper, 2022 · strength 0.11
  9. Dietrich Alexander Ruess · 1 shared paper, 2022 · strength 0.11
  10. René Bernards · 1 shared paper, 2022 · strength 0.11
  11. Sara Mainardi · 1 shared paper, 2022 · strength 0.11
  12. Bruno Sáinz · 1 shared paper, 2022 · strength 0.11
  13. Hana Algül · 1 shared paper, 2022 · strength 0.11
  14. Christian Lohrmann · 1 shared paper, 2019 · strength 0.09
  15. Eileen Mary O'Reilly · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.